Loading drug development pipeline…
Loading drug development pipeline…
Derived
For each drug, the most advanced stage supported by registered interventional trials and jurisdiction-aware approval records. Approval in any ingested jurisdiction outranks trial phase; a drug is counted once, at its highest stage.
Computedci-drug-pipeline-v1Stage rulesApprovals feed →
Funnel
Drugs reach Hodgkin Lymphoma through trial conditions or approval indications mapped to it or to one of its descendant entities.
5 drugs · 58 active trials
6 drugs · 92 active trials
Outside the funnel: Phase not stated 2. "Withdrawn" = every approval record for the scope is withdrawn or superseded; "phase not stated" = trials exist but none states a phase.
Data updated 17 hours agoSource updated unknownrecomputed with the intelligence layer
Drugs
Most advanced stage first, then most active trials. Trial counts are interventional studies linking the drug (and, when a cancer is selected, the cancer).
| Drug | Stage | Max phase | Active | Recruiting | Phase 3 | Total trials | Approvals | Jurisdictions | First approval | First trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Nivolumab | Approved | Phase 3 | 28 | 8 | 3 | 54 | 2 | US | Dec 22, 2014 | Aug 2, 2012 |
| Brentuximab Vedotin | Approved | Phase 4 | 26 | 10 | 12 | 87 | 4 | US | Aug 19, 2011 | 2006-04 |
| Pembrolizumab | Approved | Phase 3 | 21 | 11 | 3 | 49 | 1 | US | Sep 4, 2014 | Nov 22, 2013 |
| Vinblastine | Approved | Phase 4 | 17 | 7 | 8 | 42 | 1 | US | Apr 29, 1987 | Jan 25, 1994 |
| Procarbazine | Approved | Phase 3 | 0 | 0 | 2 | 5 | 1 | US | Jul 22, 1969 | 2000-03 |
| Lomustine | Approved | — | 0 | 0 | 0 | 0 | 1 | US | Aug 4, 1976 | — |
Stages describe registered activity and ingested regulatory records, not efficacy. Only ingested jurisdictions (currently US and Canada) can place a drug at "approved"; trial phases are as registered by sponsors. Nothing here is a treatment recommendation.